Abstract
Huntingtons disease is a genetic, neurodegenerative disorder causing cell dysfunction prior to cell death. Mechanisms that underlie the pathological changes continue to be elucidated, which in turn increases the number of potential therapeutic targets which have the ability to reverse or prevent further cell damage. As well as cell protection strategies, cell replacement techniques have been developed with the aim of replacing dead cells and restoring functional circuits. This review describes therapies used in clinical practice, therapies that have shown promise in experimental models either at the genetic or molecular level, and therapies that are subject to human clinical trials. It is likely that any successful therapy in clinical practice will involve a number of different approaches aimed at different targets in order to achieve both cell protection and cell replacement.
Keywords: Huntington, therapy, cell protection, cell replacement
Current Molecular Medicine
Title: Established and Emerging Therapies for Huntingtons Disease
Volume: 7 Issue: 6
Author(s): Ben L.C. Wright and Roger A. Barker
Affiliation:
Keywords: Huntington, therapy, cell protection, cell replacement
Abstract: Huntingtons disease is a genetic, neurodegenerative disorder causing cell dysfunction prior to cell death. Mechanisms that underlie the pathological changes continue to be elucidated, which in turn increases the number of potential therapeutic targets which have the ability to reverse or prevent further cell damage. As well as cell protection strategies, cell replacement techniques have been developed with the aim of replacing dead cells and restoring functional circuits. This review describes therapies used in clinical practice, therapies that have shown promise in experimental models either at the genetic or molecular level, and therapies that are subject to human clinical trials. It is likely that any successful therapy in clinical practice will involve a number of different approaches aimed at different targets in order to achieve both cell protection and cell replacement.
Export Options
About this article
Cite this article as:
Wright L.C. Ben and Barker A. Roger, Established and Emerging Therapies for Huntingtons Disease, Current Molecular Medicine 2007; 7 (6) . https://dx.doi.org/10.2174/156652407781695738
DOI https://dx.doi.org/10.2174/156652407781695738 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Common Cellular and Molecular Mechanisms Underlying Alzheimer’s Disease and Type 2 Diabetes: A Knowledge-Driven Approach
CNS & Neurological Disorders - Drug Targets Meet the Editorial Board:
Current Topics in Medicinal Chemistry Genetic Susceptibility to Behavioural and Psychological Symptoms in Alzheimer Disease
Current Alzheimer Research Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation
Recent Patents on CNS Drug Discovery (Discontinued) Clearing the Brains Cobwebs: The Role of Autophagy in Neuroprotection
Current Neuropharmacology Recent Advances in the Development of Casein Kinase 1 Inhibitors
Current Medicinal Chemistry Organotypic Hippocampal Slice Cultures for Studies of Brain Damage, Neuroprotection and Neurorepair
Current Drug Targets - CNS & Neurological Disorders Impairment of Store-operated Calcium Entry: Implications in Alzheimer’s Neurodegeneration
Current Alzheimer Research Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Synthesis, In vitro and In silico Evaluation of a Series of Pyrazolines as New Anticholinesterase Agents
Letters in Drug Design & Discovery In Silico Identification of Potential Dynamin-Related Protein 1 Antagonists: Implications for Diseases Involving Mitochondrial Dysfunction
Combinatorial Chemistry & High Throughput Screening Protein Misfolding in Disease and Small Molecule Therapies
Current Topics in Medicinal Chemistry RNA Interference: New Therapeutics in Allergic Diseases
Current Gene Therapy Role of Kynurenines in the Central and Peripherial Nervous Systems
Current Neurovascular Research Alzheimers Disease and Oxidative Stress: The Old Problem Remains Unsolved
Current Medicinal Chemistry - Central Nervous System Agents Treatment of Alzheimer's Disease: Classical Therapeutic Approach
Current Pharmaceutical Analysis T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Neuroprotective Role of Agmatine in Neurological Diseases
Current Neuropharmacology Is PrP(106-126) Fragment Involved in the Membrane Activity of the Prion Protein?
Current Protein & Peptide Science Stem Cell and Gene Therapeutic Strategies for the Treatment of Multiple Sclerosis
Current Molecular Medicine